Drug Recall: Alcolado Relampago Topical for Manufacturing Practice Deviations
Ecometics recalls Alcolado Relampago topical product nationwide due to Current Good Manufacturing Practice deviations. About 18,000 bottles in 7 oz and 16 oz sizes were distributed in the U.S.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall initiated voluntarily by the manufacturer for Current Good Manufacturing Practice deviations. No illnesses or injuries were reported, and the recall is based on process compliance issues rather than a specific identified product hazard.
Plain-English summary
Ecometics, Inc. is recalling Alcolado Relampago, a topical product containing 1% menthol and 1.5% camphor, distributed nationwide by The Larkspur Group Inc. in South Norwalk, Connecticut. The recall affects 18,000 bottles in two sizes: 7 fluid ounces (207 ml) and 16 fluid ounces (472 ml). The affected lot numbers are 2E018A, 2E021A, and 2E286A, with an expiration date of January 2025.
The recall was initiated on February 24, 2023, due to deviations from Current Good Manufacturing Practice (CGMP) standards. This is a voluntary recall initiated by the manufacturer. The FDA classified this as a Class II recall on March 8, 2023, and the recall was terminated on June 21, 2023.
Consumers should stop using the recalled product. Those who have purchased Alcolado Relampago with the affected lot numbers should check the product code and contact Ecometics, Inc. or The Larkspur Group Inc. for further information.
The recalled product
- Product
- Alcolado Relampago (menthol 1%, camphor 1.5%), packaged in a) 7 fluid oz. (207 ml) and b) 16 fluid oz. (472 ml) bottles, Distributed by: The Larkspur Group Inc. South Norwalk, CT 06854
- Manufacturer
- Ecometics, Inc.
- Category
- Drug — Topical
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: a) and b) 2E018A
- 2E021A
- 2E286A
- Exp. date Jan-25
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27